- Company Overview for REMPEX LONDON LIMITED (08194048)
- Filing history for REMPEX LONDON LIMITED (08194048)
- People for REMPEX LONDON LIMITED (08194048)
- More for REMPEX LONDON LIMITED (08194048)
Persons with significant control: 1 person with significant control / 0 statements
Melinta Therapeutics Inc.
- Correspondence address
- 300 George Street Suite 301, New Haven, Connecticut 06511, United States
- Notified on
- 5 November 2018
- Governing law
- Legal form
- Delaware Incorporated Company
- Nature of control
- Ownership of voting rights - 75% or more
- Right to appoint or remove directors
The Medicines Company Ceased
- Correspondence address
- 8 Sylvan Way, Parsippany, New Jersey, United States, 07054
- Notified on
- 6 April 2016
- Ceased on
- 5 January 2018
- Governing law
- Legal form
- Corporate
- Place registered
- The Division Of Corporations (Delaware, Usa)
- Registration number
- 2649226
- Incorporated in
- United States
- Nature of control
- Ownership of voting rights - 75% or more
- Right to appoint or remove directors